Business Wire

  1. How Pharma Can Get Into The Social Media Mix: Industry Expert Will Detail Three Essential Steps During Remarks At PRSA Health Academy Annual Conference 4/16/2009
    Josh Bernoff, co-author of the best-selling book, “Groundswell: Winning in a World Transformed by Social Technologies” (Harvard Business Press), and vice president and principal analyst at Forrester Research, will present recent data and insights on social technology strategies that succeed within the health care industry as a guest keynote speaker at the Public Relations Society of America (PRSA) 2009 Health Academy Conference, May 13–15, in Washington, D.C.
  2. Midatech Forms PharMida AG, A New Life Science Subsidiary Applying Nanotechnology To Drug Discovery And Development 11/18/2008
    Midatech Group, a world leader in nanotechnology, today announces the formation of a Basel-based Swiss drug development subsidiary, PharMida AG. Formation of this subsidiary follows an investment by a group of Switzerland-based private investors into Midatech Ltd.
  3. Bio-Path Holdings, Inc. Announces The Signing Of A Drug Manufacturing Agreement With Althea Technologies, Inc. 11/18/2008
    Bio-Path Holdings, Inc., a publicly traded biotechnology company with drug development operations in Houston, Texas (symbol OTCBB: BPTH), announced today it has entered into a drug manufacturing agreement with Althea Technologies, Inc.
  4. Redpoint Bio Signs Pharmaceutical Research Agreement With Schering Corporation 11/17/2008
    Redpoint Bio Corporation, today announced that it has signed an agreement to collaborate with Schering Corporation, a subsidiary of Schering-Plough Corporation (NYSE: SGP), in the area of taste science research for pharmaceutical applications.
  5. Pfizer Launches Global Regenerative Medicine Research Unit 11/14/2008
    Pfizer today announced the launch of a new research unit known as Pfizer Regenerative Medicine. This independent research unit will build on recent scientific progress in understanding the biology of stem cells and the opportunity that provides, to discover and develop a new generation of regenerative medicines for major medical needs.
  6. AnaSpec Establishes New Dedicated GMP Manufacturing Facility 11/14/2008
    In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing.
  7. Conformia Solution Enables An Integrated Information Environment For Pharmaceutical And Biotech Industries 11/13/2008
    Conformia, today announced the availability of an "out-of-the-box" Integrated Information Environment for large pharmaceutical and biotechnology process/product development divisions.
  8. Gain A Valuable Insight Into India's Pharmaceutical Regulatory Environment For 2008 In This Comprehensive Report 11/10/2008
    Research and Markets has announced the addition of the "India Pharmaceutical Regulatory Report 2008 (with appendix)" report to their offering.
  9. Pfizer Discontinues Development Program For Its Phase 3 Obesity Compound (CP-945,598) 11/7/2008
    Pfizer, Inc announced that it is terminating the phase 3 development program for its investigational compound (CP-945,598) for weight management.
  10. Applied Biosystems And Asuragen Collaborate With The Critical Path Institute To Improve Drug Toxicity Screening 11/7/2008
    Drug toxicity accounts for billions of lost dollars to the pharmaceutical industry each year and is a leading cause of pre-clinical drug failures.